Business Context and Reporting Period
Company: American Vanguard Corp
Filing Type: Form 8-K (Current Report)
Report Date: January 16, 2008
Event Date: January 16, 2008
This filing reports a material corporate event involving the Company's wholly-owned subsidiary, AMVAC Chemical Corporation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate transaction rather than periodic financial performance.
Material Changes
- Acquisition Completed: On January 16, 2008, AMVAC Chemical Corporation completed the acquisition of the Orthene® insecticide product line from Valent U.S.A. Corporation.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors related to this transaction. The report references a press release (Exhibit 99.1) for further details on the acquisition.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific terms of the Orthene® acquisition.
- Verify the strategic rationale for acquiring the insecticide product line from Valent U.S.A. Corporation.
- Check subsequent filings for any financial impact or integration costs associated with the acquisition.